Insulet Financial Statements From 2010 to 2026

PODD Stock  USD 250.85  1.56  0.62%   
Insulet's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Insulet's valuation are provided below:
Gross Profit
1.8 B
Profit Margin
0.0976
Market Capitalization
17.8 B
Enterprise Value Revenue
6.9523
Revenue
2.5 B
There are over one hundred nineteen available fundamental trends for Insulet, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Insulet's regular performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 9.8 B. The current year's Enterprise Value is expected to grow to about 10.5 B

Insulet Total Revenue

2.5 Billion

Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet's main balance sheet or income statement drivers, such as Interest Expense of 51.6 M, Other Operating Expenses of 2.1 B or Operating Income of 373 M, as well as many indicators such as Price To Sales Ratio of 15.94, Dividend Yield of 0.0 or PTB Ratio of 19.9. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.
  
Build AI portfolio with Insulet Stock
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Insulet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.7 B3.6 B1.4 B
Slightly volatile
Cash1.2 B1.1 B465.3 M
Slightly volatile
Other Assets1.091.1524.1 M
Pretty Stable
Cash And Short Term Investments1.2 B1.1 B489.1 M
Slightly volatile
Common Stock Shares Outstanding46.3 M85 M57.8 M
Slightly volatile
Liabilities And Stockholders Equity3.7 B3.6 B1.4 B
Slightly volatile
Total Liabilities2.3 B2.2 B969.3 M
Slightly volatile
Total Current Assets2.3 B2.2 B854.9 M
Slightly volatile
Short and Long Term Debt Total1.7 B1.6 B769.7 M
Slightly volatile
Total Current Liabilities638 M607.7 M215.9 M
Slightly volatile
Short Term Debt52.6 M98.8 M57.3 M
Pretty Stable
Property Plant And Equipment Net917.5 M873.8 M344.5 M
Slightly volatile
Accounts Payable19.8 M22.8 M23.1 M
Slightly volatile
Non Current Assets Total1.5 B1.4 B543 M
Slightly volatile
Non Currrent Assets Other192.5 M183.3 M68.5 M
Slightly volatile
Common Stock Total Equity120.8 K115 K75 K
Slightly volatile
Non Current Liabilities Total1.6 B1.5 B755.3 M
Slightly volatile
Property Plant And Equipment Gross1.3 B1.2 B447.2 M
Slightly volatile
Common Stock61.9 K115 K71.5 K
Slightly volatile
Other Liabilities5.4 M9.5 M6.6 M
Slightly volatile
Long Term Debt1.6 B1.5 B731.7 M
Slightly volatile
Net Receivables441.3 M420.3 M144.2 M
Slightly volatile
Inventory519.7 M495 M173.9 M
Slightly volatile
Property Plant Equipment724.4 M689.9 M306.1 M
Slightly volatile
Good Will45 M59.2 M41.4 M
Slightly volatile
Long Term Debt Total1.7 B1.6 B754 M
Slightly volatile
Capital Surpluse899.1 M1.2 B852.8 M
Slightly volatile
Non Current Liabilities Other62.3 M59.3 M19.7 M
Slightly volatile
Intangible Assets118.9 M113.3 M41.9 M
Slightly volatile
Capital Lease Obligations230 K242.1 K1.6 M
Slightly volatile
Short and Long Term Debt129.8 M86.4 M140.3 M
Slightly volatile
Net Invested Capital1.6 BB1.2 B
Slightly volatile
Net Working Capital937.2 M1.6 B734 M
Slightly volatile
Capital Stock103.6 K115 K79.4 K
Slightly volatile

Insulet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2.1 BB818 M
Slightly volatile
Research Development265.2 M252.5 M113.5 M
Slightly volatile
Total Operating Expenses1.4 B1.3 B511.2 M
Slightly volatile
Selling And Marketing Expenses74.5 M96.9 M75.1 M
Slightly volatile
Depreciation And Amortization97.6 M92.9 M38.3 M
Slightly volatile
Selling General AdministrativeB957.8 M325.8 M
Slightly volatile
Total Revenue2.5 B2.4 B897.5 M
Slightly volatile
Cost Of Revenue755.8 M719.8 M306.9 M
Slightly volatile
Interest Income47.7 M45.4 M16.7 M
Slightly volatile
Reconciled Depreciation52.9 M92.9 M36.9 M
Slightly volatile

Insulet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow850.3 M809.8 M365.4 M
Slightly volatile
Depreciation97.6 M92.9 M38.3 M
Slightly volatile
Capital Expenditures150.8 M143.6 M84 M
Slightly volatile
End Period Cash Flow1.2 B1.1 B450.6 M
Slightly volatile
Change To Liabilities158.8 M151.2 M51.9 M
Slightly volatile
Stock Based Compensation83.7 M79.7 M34.6 M
Slightly volatile
Change To Netincome40.7 M55.1 M38 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.9410.1615.5305
Slightly volatile
Days Sales Outstanding73.4474.0659.2739
Pretty Stable
Stock Based Compensation To Revenue0.0590.03850.0526
Slightly volatile
Capex To Depreciation3.231.783.0488
Very volatile
EV To Sales18.2110.4218.5129
Slightly volatile
Inventory Turnover1.591.674.6528
Slightly volatile
Days Of Inventory On Hand237226150
Slightly volatile
Payables Turnover29.8728.4513.395
Slightly volatile
Research And Ddevelopement To Revenue0.120.10612.7911
Slightly volatile
Capex To Revenue0.06590.06936.5339
Slightly volatile
Cash Per Share16.2715.6510.8899
Very volatile
Days Payables Outstanding12.6113.2857.3145
Slightly volatile
Intangibles To Total Assets0.05310.05590.1139
Slightly volatile
Current Ratio3.874.0727.2628
Slightly volatile
Receivables Turnover4.985.16.8423
Very volatile
Graham Number45.5443.3711.7468
Slightly volatile
Capex Per Share3.182.051.9046
Very volatile
Average Receivables24.6 M29.9 M31.6 M
Very volatile
Revenue Per Share27.9426.6112.7023
Slightly volatile
Interest Debt Per Share19.7518.8111.5398
Slightly volatile
Debt To Assets0.420.410.5473
Pretty Stable
Operating Cycle269363263
Very volatile
Days Of Payables Outstanding12.6113.2857.3145
Slightly volatile
Ebt Per Ebit1.571.121.4131
Slightly volatile
Quick Ratio2.983.1426.6588
Slightly volatile
Net Income Per E B T1.051.60.9938
Very volatile
Cash Ratio1.972.0725.5236
Slightly volatile
Cash Conversion Cycle201349202
Pretty Stable
Days Of Inventory Outstanding237226150
Slightly volatile
Days Of Sales Outstanding73.4474.0659.2739
Pretty Stable
Fixed Asset Turnover4.413.144.2792
Slightly volatile
Debt Ratio0.420.410.5473
Pretty Stable
Price Sales Ratio15.9410.1615.5305
Slightly volatile
Asset Turnover0.460.60.6576
Pretty Stable

Insulet Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.8 B9.3 B7.1 B
Slightly volatile
Enterprise Value10.5 B10 B7.6 B
Slightly volatile

Insulet Fundamental Market Drivers

Forward Price Earnings40.3226
Cash And Short Term Investments953.4 M

Insulet Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Insulet Financial Statements

Insulet stakeholders use historical fundamental indicators, such as Insulet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Insulet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insulet's assets and liabilities are reflected in the revenues and expenses on Insulet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insulet. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue13.8 M14.5 M
Total Revenue2.4 B2.5 B
Cost Of Revenue719.8 M755.8 M
Stock Based Compensation To Revenue 0.04  0.06 
Research And Ddevelopement To Revenue 0.11  0.12 
Capex To Revenue 0.07  0.07 
Revenue Per Share 26.61  27.94 
Ebit Per Revenue 0.13  0.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Health Care Equipment & Supplies sector continue expanding? Could Insulet diversify its offerings? Factors like these will boost the valuation of Insulet. Anticipated expansion of Insulet directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insulet data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.148
Earnings Share
3.53
Revenue Per Share
35.873
Quarterly Revenue Growth
0.299
Return On Assets
0.0874
Understanding Insulet requires distinguishing between market price and book value, where the latter reflects Insulet's accounting equity. The concept of intrinsic value - what Insulet's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Insulet's price substantially above or below its fundamental value.
It's important to distinguish between Insulet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Insulet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Insulet's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.